IDSA : View All Letters to Congress on Strengthening Immunizations

06/25/2008

IDSA Joins Coalition Letter on Vaccines (PDF)

IDSA signed a coalition letter to the House Appropriations Committee opposing any legislation that would restrict the use, or limit the availability, of recommended vaccines due to the use of thimerosal as a preservative or other reasons.

06/02/2008

IDSA Signs Open Letter to Congress on Immunization Policy (PDF)

IDSA joined with several other public health organizations to send a letter to Congress in support of scientifically valid immunization policies.

05/07/2008

IDSA Endorses Waxman Legislation on Vaccine Access (PDF)

Letter of IDSA's endorsement for H.R. 4990, the Vaccines for Children Access Act of 2008, and H.R. 4993, the Vaccines for the Uninsured Adult Act of 2008, two critical pieces of legislation will provide access to vaccines for millions of children, adolescents and adults and help reduce the number of vaccine-preventable deaths in this country.

11/15/2007

IDSA Endorses 50% Tax Credit for ID Product R&D (PDF)

New legislation, S. 2351, introduced by Senator Charles Schumer (D-NY), if enacted, will help to spur the development of new antibiotics, antiviral drugs, vaccines, diagnostics, and biological products to address MRSA, gram-negative bacterial infections, XDR-TB, and other dangerous drug-resistant and other infectious pathogens.

07/16/2007

IDSA, Others Oppose the Weldon Amendment Concerning Thimerosal (PDF)

IDSA and others oppose a legislative amendment that would prohibit the use of federal funds to administer an influenza vaccine containing the preservative thimerosal to children less than 3 years of age in the 2008-2009 influenza season.

11/09/2006

IDSA Urges Cures for Immunization Shortfalls at CDC (PDF)

IDSA asks appropriators to fund the cost of a new CDC adolescent immunization survey and also commit to increase funding for national immunization efforts.

04/03/2006

IDSA Signs on to Letter Opposing Efforts to Restrict Access to Vaccines (PDF)

IDSA signed a letter to Congress with other immunization groups to oppose legislation which restricts access to vaccines that contain thimerosal.

11/08/2005

IDSA Opposes Legislation Stifling Biotech and Device R&D (PDF)

IDSA joins patient groups, medical health advocates, biotechnology and medical device companies to support legislative fix to regulations that threaten to stifle promising research on new drugs, vaccines and diagnostics that could improve health and save lives.

07/05/2005

IDSA Endorses the Infectious Disease Research and Development Act of 2005 (PDF)

IDSA endorsed H.R. 3154, the Infectious Diseases Research and Development Act of 2005, which, if enacted, would provide incentives for companies to invest in research and development of antibiotics, antivirals, diagnostics, and vaccines that identify, treat, or prevent a “qualified infectious disease product.”

10/29/2004

View All Letters to Congress on Strengthening Immunizations

IDSA Joins Coalition Letter on Vaccines (PDF)

IDSA Signs Open Letter to Congress on Immunization Policy (PDF)

IDSA Endorses Waxman Legislation on Vaccine Access (PDF)

IDSA Endorses 50% Tax Credit for ID Product R&D (PDF)

IDSA, Others Oppose the Weldon Amendment Concerning Thimerosal (PDF)

IDSA Urges Cures for Immunization Shortfalls at CDC (PDF)

IDSA Signs on to Letter Opposing Efforts to Restrict Access to Vaccines (PDF)

IDSA Opposes Legislation Stifling Biotech and Device R&D (PDF)

IDSA Endorses the Infectious Disease Research and Development Act of 2005 (PDF)

Concern about the Hypothetical Association between Thimerosal in Vaccines and Autism (PDF)

Improved Vaccine Affordability and Availability (PDF)

Scientific Advisory Committee Funding (PDF)

Infectious Diseases Society of America